Search
Rein Therapeutics Inc
RNTXAdd to Watchlist
0.992USD
+0.013+1.38%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
27.80MMarket Cap
LossP/E TTM
Rein Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Rein Therapeutics Inc is 8.46, ranking 131 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.52, which is -59.87% below the recent high of -0.21 and -288.49% above the recent low of -2.03.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.